Advertisement

Topics

Magenta Therapeutics Sets Sights on $100 Million IPO To Advance Bone Marrow Transplant Programs

20:00 EDT 24 May 2018 | BioSpace

Weeks after securing $52 million in a Series C financing, Magenta Therapeutics is eying the raising of $100 million in an initial public offering two years after it was launched by Third Rock Ventures and Atlas Venture with $48.5 million in Series A financing.

Original Article: Magenta Therapeutics Sets Sights on $100 Million IPO To Advance Bone Marrow Transplant Programs

NEXT ARTICLE

More From BioPortfolio on "Magenta Therapeutics Sets Sights on $100 Million IPO To Advance Bone Marrow Transplant Programs"

Advertisement
Quick Search
Advertisement
Advertisement